Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese Survey Finds Wide Diabetes Blood Device Reuse

This article was originally published in PharmAsia News

Executive Summary

A national survey disclosed 13,408 health institutions such as hospitals and clinics reused devices for drawing blood drops for diabetes tests. The Ministry of Health, Labor and Welfare conducted the survey after it was revealed in May that a clinic had used the same blood-drawing needle on many patients. In all but three cases, the part of the device that was reused was limited to the cap that encloses the needle. Only three institutions actually reused the needles themselves. The ministry said no health problems have been reported as a result of the practice. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069471

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel